scholarly journals Flu and Tdap Maternal Immunization Hesitancy in Times of COVID-19: An Italian Survey on Multiethnic Sample

Vaccines ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1107
Author(s):  
Anna Franca Cavaliere ◽  
Simona Zaami ◽  
Marta Pallottini ◽  
Federica Perelli ◽  
Annalisa Vidiri ◽  
...  

Background: Tdap and flu immunization in pregnancy has been proven to be both effective and safe. Despite this, the vaccination rate in pregnant women is low in Italy. The COVID-19 pandemic has focused the attention of public opinion on communicable diseases, underlining the importance of primary prevention measures such as vaccination. We conducted a survey to investigate the behavior of pregnant women during the COVID-19 pandemic regarding maternal immunization to identify the reasons for vaccine hesitancy in order to overcome them. The new challenge is COVID-19 vaccination in pregnancy, and preliminary data show hesitancy towards it. Our analysis may be useful to improve immunization in the pregnant population, including through the COVID-19 vaccine. Methods: A targeted survey was performed in Italy including 520 women who experienced in the first trimester of pregnancy, prior to the novel coronavirus spread, the 2019–2020 influenza vaccination campaign and the Tdap vaccine recommendation in the third trimester during the COVID pandemic. They represent a unique model to investigate if the new coronavirus outbreak might have changed attitudes towards vaccination in pregnancy in the same patients. Data were collected from a self-completed paper questionnaire. Descriptive statistics were calculated and percentages were compared using the chi-2 test or Fisher’s exact test. Results: We obtained data from 195 of the 520 women who gave birth during the inclusion period; 325 cases declined to participate in the survey. A total of 8.7% (17 cases) performed flu vaccination in the first trimester of pregnancy (pre-COVID era), 50.8% (99 cases) accepted Tdap immunization during their third trimester of gestation (COVID-19 pandemic) and 6.7% (13 cases) received both vaccines during pregnancy. For both the flu and Tdap shots, pregnant patients were more likely to accept the vaccines if they were recommended by a healthcare provider, whereas the main reason not to be vaccinated was the lack of such a recommendation. Conclusions: Our survey shows that the COVID-19 experience, which has raised awareness as to the role of vaccines in preventable diseases, may positively change attitudes toward immunization in pregnancy. Vaccination must be recommended to all pregnant women and organized during routine prenatal care as an important element for the prevention of communicable diseases. Vaccination hesitancy can be minimized through consistent recommendation to all pregnant women offered by obstetric staff during routine prenatal care. This approach is likely to be effective in terms of building trust in flu and Tdpa immunization among pregnant women, as well as to avoid unjustified hesitancy towards the more recent COVID-19 vaccines.

2016 ◽  
Vol 65 (6) ◽  
pp. 28-35
Author(s):  
Irina V Borisova

The aim of the study was evaluation of clinical and laboratory manifestations of drug-induced cytolytic syndrome in pregnancy. In the research group included 62 pregnant women with drug-induced liver injury (DILI) in the first trimester of pregnancy. These pregnant women received hormone therapy at the planning stage and/or during pregnancy for the prevention and treatment of miscarriage and had clinical and biochemical manifestations of cytolytic syndrome. Pregnancy after IVF and ovulation induction was in 60.8% of cases. Hormone therapy for pregnant patients received long-term, 85% of pregnant women used estrogen and progestin drugs. DILI during pregnancy characterized by low-symptom or asymptomatic clinical manifestations. DILI manifested cytolytic biochemical syndrome, in which there is isolated increase of transaminase levels, in some cases accompanied by increased level of gamma glutamyl transpeptidase, liver glutamate dehydrogenase and decreased total protein levels, in the first place due to the albumin fraction.


1996 ◽  
Vol 270 (3) ◽  
pp. G506-G514 ◽  
Author(s):  
J. W. Walsh ◽  
W. L. Hasler ◽  
C. E. Nugent ◽  
C. Owyang

Women in pregnancy experience nausea, which correlates with gastric slow-wave rhythm disruption. Mediators of these dysrhythmias were explored. To quantitate slow-wave disruption, eight pregnant women with first-trimester nausea underwent electrogastrography after a 250-kcal meal. Results were compared with nonpregnant women with nausea during a prior pregnancy who received estradiol and/or progesterone to levels of the first trimester of pregnancy. Five pregnant women exhibited dysrhythmias, with increases in combined recording time in tachygastria plus bradygastria, as well as decreases in the percentage of electrogastrography signal power in the normal 3 cycle/min range (cpm), compared with nonpregnant women (P<0.05). Estradiol did not evoke dysrhythmias in nonpregnant women; however, progesterone induced increases in recording time in bradygastria plus tachygastria and increases in bradygastric signal power with corresponding decreases in signal power in the 3-cpm range (P<0.05). With estradiol and progesterone coadministration, an additive effect was observed at 3.3 +/- 0.8 h, with increased recording time in bradygastria alone and in bradygastria plus tachygastria with corresponding increases in bradygastric signal power and decreases in power in the 3-cpm range (P<0.05). In conclusion, women with nausea of pregnancy exhibit slow-wave rhythm disruption. Similar dysrhythmias are evoked in nonpregnant women by progesterone alone or in combination with estradiol in doses that reproduce levels in pregnancy. Thus gastric dysrhythmias in pregnancy may be due to a combination of elevated progesterone and estrogen levels.


2010 ◽  
Vol 76 (3) ◽  
pp. 302-305 ◽  
Author(s):  
Kristen M. Blaker ◽  
Sunati Sahoo ◽  
Maria R. Schweichler ◽  
Anees B. Chagpar

Malignant phylloides tumors are exceedingly rare with few cases being reported in pregnancy. We describe the first case ever reported of a malignant phylloides tumor presenting in the first trimester of pregnancy and provide insight into the complexities of management as well as a review of the known literature. An extensive PubMed literature search for “cystosarcoma,” “phylloides,” and “pregnancy” was performed. References of each citation were reviewed. Only six previous cases of phylloides tumor in pregnancy were found, none of which were in the first trimester. Medical records of a patient presenting to our institution at 9 weeks gestation with a malignant phylloides tumor were reviewed. We further provide a review of the current literature of the management of phylloides tumor in pregnancy. A 27-year-old white G2P0SA1 woman with no family history of breast cancer presented with a right breast mass at her first prenatal examination at 9 weeks of pregnancy. Ultrasound confirmed a solid mass measuring 24 mm. Core needle biopsy demonstrated a malignant phylloides tumor. She previously had a fibroadenoma removed from the same breast 7 years previously. The current tumor was excised to clear margins. Histopathological examination revealed a 4-cm fibroepithelial tumor with marked stromal cellularity and a high mitotic count (five to seven mitoses/high-power field), confirming the diagnosis of malignant phylloides tumor. The patient continued her pregnancy without complications. Six other cases of phylloides tumor presenting in pregnancy have been reported in the literature, one of which had bilateral disease. Of these, the average patient age was 32 years (range, 28 to 35 years). The majority of these patients presented in their third trimester (mean, 29 weeks; range, 20 to 36 weeks) and often had large tumors (mean, 15 cm; range, 5 to 21 cm). Four of the seven tumors (57%) required a mastectomy. Previous cases have shown phylloides tumors to present in the third trimester as large masses that require mastectomy. With early detection, malignant phylloides tumors can present in the first trimester of pregnancy at smaller sizes; in these patients, breast-conserving surgery is possible.


2014 ◽  
Vol 56 (2) ◽  
pp. 133-138 ◽  
Author(s):  
Maria F.M. Barral ◽  
Gisele R. de Oliveira ◽  
Rubens C. Lobato ◽  
Raul A. Mendoza-Sassi ◽  
Ana M.b. Martínez ◽  
...  

In the absence of intervention, the rate of vertical transmission of HIV can range from 15-45%. With the inclusion of antiretroviral drugs during pregnancy and the choice of delivery route this amounts to less than 2%. However ARV use during pregnancy has generated several questions regarding the adverse effects of the gestational and neonatal outcome. This study aims to analyze the risk factors for vertical transmission of HIV-1 seropositive pregnant women living in Rio Grande and the influence of the use of ARVs in pregnancy outcome. Among the 262 pregnant women studied the rate of vertical transmission of HIV was found to be 3.8%. Regarding the VT, there was a lower risk of transmission when antiretroviral drugs were used and prenatal care was conducted at the referral service. However, the use of ART did not influence the outcome of pregnancy. However, initiation of prenatal care after the first trimester had an influence on low birth weight, as well as performance of less than six visits increased the risk of prematurity. Therefore, the risk factors analyzed in this study appear to be related to the realization of inadequate pre-natal and maternal behavior.


Author(s):  
І. Yu. Kostyuk ◽  
G. V. Chayka ◽  
M. S. Storozhuk ◽  
О.К. Таrаsiuk

One of the most important problems of modern urogynecology is the improvement of the treatment-diagnostic algorithm and prevention of overactive bladder syndrome (OAB). The purpose of the work is to construct and analyze discriminant models of the possibility of OAB occurrence in pregnant women of different age groups depending on the characteristics of anthropo-somatotypological indicators or hormonal background. 75 pregnant women with clinical signs of OAB syndrome and 60 healthy pregnant women had hormonal screening in the 1st and 3rd trimester of pregnancy and at 16 weeks postpartum using radioimmunoassay and immune enzyme methods (estradiol, progesterone, thyroid stimulating hormone and testosterone levels were determined). The anthropometry was carried out according to the method of V. V. Bunak, the components of the somatotype were determined according to the method of J. Carter and B. Heath, as well as the components of the body composition according to the method of J. Matiegka and the American Institute of Nutrition (AIN). By age, all pregnant women were divided into 3 subgroups: І - from 17 to 25 years, ІІ - from 26 to 35 years, ІІІ - from 36 to 41 years. A discriminant analysis of the possibility of OAB occurrence, depending on the anthropo-somatotypological or hormonal indices in women of different age groups, was conducted using the licensing program “Statistica 5.5”. When taken into account anthropo-somatotypological indices in women aged from 17 to 25 years, the model is correct in 86.7% of cases; in women aged from 26 to 35 years - in 90.9% of cases; in women between the ages of 36 and 41 years - in 89.3% of cases. Between healthy and OAB patients, women aged from 17 to 25 years discriminating variables are the width of the distal epiphysis of the shoulder (which has the greatest contribution to discrimination), conjugata externa, the muscle component of the body weight by AIN and the forearm's girth in the upper third; women from 26 to 35 years - dist. Іntеrtrochantericа, the width of the distal epiphyses of the forearm (the greatest contribution to discrimination), hip circumference, conjugata externa, mesomorphic component of the somatotype according to by Heath-Carter, fat mass component of the body by Matiegka, the forearm's girth in the upper third and the shoulder girth; women of age from 36 to 41 years - the width of the distal epiphysis of the leg (which has the greatest contribution to discrimination) and the length of the body. In general, the aggregate of all variables has a low level of discrimination between healthy and sick with OAB women between the ages of 17 and 25 (Wilkes Lambda statistics = 0.531; F = 5.521; p <0.01) and 36-41 years (Wilkes Lambda statistics = 0.445; F = 15.62; p <0.001), while among women between the ages of 26 and 35 - the average level of discrimination (Wilkes Lambda statistics = 0.386; F = 13.52; p <0.001). When taken into account characteristics of the hormonal background in women of all ages, the model is correct in 100% of cases. Between healthy and OAB patients, of 17-25 years age, discriminant variables are estradiol levels at 16 weeks of postpartum (with the largest contribution to discrimination) and prolactin levels in the first trimester of pregnancy; women aged from 26 to 35 years - estradiol levels at 16 weeks of postpartum (the most contributing to discrimination), testosterone in the third trimester of pregnancy, estradiol in the third trimester of pregnancy, prolactin in the third trimester of pregnancy, estradiol in the first trimester of pregnancy, and testosterone levels in the first trimester of pregnancy; women aged from 36 to 41 years - estradiol in the third trimester of pregnancy (has the largest contribution to discrimination) and estradiol in the 16 weeks of postpartum period. In general, the totality of all variables has a low level of discrimination between healthy and sick at OAB women between the ages of 17 and 25 (Wilkes Lambda statistics = 0.619; F = 131.4; p <0.001) and ages 26-35 (Wilks Lambda statistics = 0.493; F = 224.9; p <0.001), while among women between the ages of 36 and 41 - the average level of discrimination (Wilkes Lambda statistics = 0.371; F = 207.4; p <0.001). Thus, with the aid of discriminant analysis, reliable models of the possibility of OAB occurrence, based on anthropo-somatotypological or hormonal indices in women of different age groups, are constructed. In all age groups, the greatest contribution to discrimination between healthy and sick with OAB pregnant women, in most cases, make parameters of the width of distal epiphyses of long limb bones or the level of estradiol.


Author(s):  
Samuel Dockree ◽  
Jennifer Brook ◽  
Brian Shine ◽  
Tim James ◽  
Manu Vatish

Abstract Background Cardiac disease is the leading cause of maternal mortality in the UK, so accurate cardiovascular diagnoses in pregnancy are essential. BNP (B-type natriuretic peptide) and NT-pro BNP (N-terminal-pro BNP) are useful clinical tools for investigating suspected peripartum cardiomyopathy but, as the pregnancy-specific reference intervals are undefined, it is uncertain how they should be interpreted in pregnant women. Methods Longitudinal study of 260 healthy pregnant women, with sampling in each trimester to define 95% reference intervals. Results The upper reference limit for NT-pro BNP was 200 pg/mL in the first and second trimesters, and 150 pg/mL in the third. Levels were significantly reduced in overweight women in the third trimester (p=0.0001), which supports the partitioning of reference intervals by BMI. The upper limit for BNP was 50 pg/mL, with no detectable trimester-related differences. Whilst other biomarkers (haemoglobin and platelets) fell throughout pregnancy, both natriuretic peptides were initially elevated before falling by the third trimester, suggesting that the observed changes in natriuretic peptides are driven by dynamic interplay between cardiac strain and progressive haemodilution. NT-pro BNP in the first trimester was inversely associated with neonatal birthweight at term (p=0.011). Conclusions Cardiac biomarkers have an important role for investigating suspected disease in high-risk pregnant women, but a robust assessment of the levels expected in healthy pregnant women is an essential prerequisite to their application in clinical practice. This study has defined trimester- and BMI-specific reference intervals for NT-pro BNP and BNP, which may improve how women with suspected cardiovascular disease are investigated in pregnancy.


2021 ◽  
Vol 11 (5-S) ◽  
pp. 71-76
Author(s):  
Mahamadou BALLO ◽  
Karim Traoré ◽  
Samou Sidibé ◽  
Seidina Diakité ◽  
Abdoulaye Guindo ◽  
...  

Malaria infections in pregnancy should be treated promptly with safe and efficacious antimalarial drugs to prevent harmful effects on the mother and fetus. To succeed, the Malian has developed NMCP guidelines for the management of malaria cases in pregnant women. The study aimed at the analysis of the prescription of antimalarial drugs based on the Mali's NMCP guidelines. We conducted a cross-sectional study during malaria transmission season from June to August 2020. The sampling concerned all prescriptions for pregnant women containing at least one antimalarial drug. The frequency of prescription of antimalarial drugs was 85%. 132 (74.16%) were preventive treatments and 46 (25.84%) curative treatments. 30 (90.91%) of pregnant women in the first trimester received one dose of Sulfadoxine-Pyrimethamine. 6 (12.5%) received three doses in the third trimester. Of the 46 antimalarial drugs prescribed for the treatment of uncomplicated malaria, 30 (65.22%) were Artemether-lumefantrine (tablet), 10 (21.74%) were Quinine (tablet). 29 (63.04%) were compliant with NMCP guidelines and 17 (36.96%) were not. The non-compliances concerned 3 prescriptions of Artemether-lumefantrine in the first trimester, 3 and 5 prescriptions of Quinine (tablet) in the second and third trimester respectively and at the end 2 and 4 non-compliances respectively for the prescription of injectable dosage forms of Quinine and Artesunate. This study showed a great noncompliance with the Mali's NMCP guidelines in the prescription of antimalarial in pregnant women. Chemoprophylaxis should be prohibited in the first trimester.   Keywords: Curative and Preventive Treatment, Malaria in Pregnancy, Malaria Transmission, Mali


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chin-Ru Ker ◽  
Chen-Hsuan Wu ◽  
Chien-Hung Lee ◽  
Shih-Han Wang ◽  
Te-Fu Chan

AbstractThe association among sugar sweetened beverages (SSB) consumption, addiction and depression in adults, children and adolescents is widely reported. Dieting patterns during pregnancy is complicated by maternal fetal concerns. Specifically, restrained use of SSB might be potentially a source of perinatal distress. The current study modified diagnostic criteria for Substance Use Disorder (SUD) in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), into SSB-specific questions to assess SSB use tendency. Edinburgh Postpartum Depression Scores (EPDS) is used to assess maternal distress during pregnancy. One hundred and ninety-six consecutive pregnant women receiving antenatal care at Kaohsiung Medical University Hospital were invited to participate in this study. In the first trimester, 46.6% of women had none or 1 DSM-5 symptom, 27.0% had 2–3 symptoms, while 26.4% had ≥ 4 symptoms. The mean numbers of DSM-5 symptoms in each trimester were found to be 2.5 ± 2.25, 2.6 ± 2.45, 2.4 ± 2.43 for the first, second and third trimester, respectively, p = 0.750. While EPDS score showed no difference among DSM-5 symptoms 0–1, 2–3 and ≥ 4 groups in the first trimester (8.1 ± 4.59, 8.4 ± 5.00, 8.8 ± 4.82, p = 0.343), women with ≥ 4 DSM-symptoms was found significantly higher EPDS scores than those with < 4 DSM-symptoms in the second (7.2 ± 4.81, 7.7 ± 4.98, 8.8 ± 4.33, p = 0.030) and third trimester (6.8 ± 5.00, 7.2 ± 4.63, 8.7 ± 5.24, p = 0.019). The relationship remained significant after adjusting for covariates including actual SSB amount consumed (adjusted β = 0.25 with 95% confident interval (CI) 0.04–0.45 and 0.21 with 95% CI 0.04–0.38 for the second and third trimesters, respectively). Overall, the study is the first to characterize the positive relationship between SSB use tendency and antenatal distress in pregnancy, independent of actual SSB amount consumed. The observational nature of the study design precludes inferences of its underlying socio-psychomotor mechanisms, although restrained SSB use in pregnancy is suspected to contribute. The novel employment of modified SSB-specific DSM-5 scores and EPDS in this setting is feasible and further validation is promising. With better understanding and awareness, pregnant women with increased SSB use tendency should be properly counseled with special attention to their mental state.


2011 ◽  
Vol 5 (6) ◽  
pp. 1463
Author(s):  
Alessandra Nogueira Cabral ◽  
Lilian Márcia Vieira ◽  
Andréa Mathes Faustino ◽  
Paula Elaine Diniz dos Reis

ABSTRACTObjective: to identify the knowledge on hypertension in pregnancy among pregnant women followed up at a primary care unit for prenatal care. Methodology: this is a sectional study, with a survey design, whose population consisted of pregnant women assisted in a Health Centre in the Distrito Federal–DF, Brazil. The selection criteria were: being over 18 years, being in the first trimester of pregnancy, and voluntarily agreeing to participate in the research. After consent, a questionnaire developed by the authors was applied. The study was approved by the Committee of Ethics in Research of the Fundação de Ensino e Pesquisa em Ciências da Saúde, under the Protocol 191/09. The data were analyzed through descriptive statistics. Results: the sample consisted of 30 women, mean age 26 years, most of them housewives. With regard to the knowledge on hypertension in pregnancy, 77.33% had heard about the issue, however, they were not able to identify aspects of prevention, risk factors, and complications of this disease. Conclusion: deficits in knowledge on hypertension in pregnancy is a risk factor of mortality for pregnant women. One expects the data from this study alert health professionals for the approach of the theme during the pre-natal consultations. Descriptors: hypertension in pregnancy; eclampsia; knowledge; pregnant women.RESUMOObjetivo: identificar o conhecimento acerca da hipertensão na gravidez entre gestantes acompanhadas em serviço de saúde primário para pré-natal. Metodologia: trata-se de estudo seccional, do tipo survey, cuja população foi de gestantes atendidas em um Centro de Saúde do Distrito Federal–DF, Brasil. Os critérios de seleção foram: ser maior de 18 anos, estar no primeiro trimestre gestacional e concordar em participar de forma voluntária da pesquisa. Após o consentimento, foi aplicado questionário elaborado pelas autoras. O estudo foi aprovado pelo Comitê de Ética em Pesquisa da Fundação de Ensino e Pesquisa em Ciências da Saúde, sob Protocolo n. 191/09. Os dados foram analisados por meio de estatística descritiva. Resultados: a amostra foi constituída por 30 mulheres, com idade média de 26 anos, sendo a maioria do lar. Acerca do conhecimento sobre hipertensão na gravidez, 77,33% tinham ouvido falar sobre o assunto, contudo, não souberam identificar aspectos de prevenção, fatores de risco e complicações dessa doença. Conclusão: déficits de conhecimento sobre hipertensão na gravidez é um fator de risco de mortalidade para gestantes. Espera-se com os dados deste estudo alertar os profissionais de saúde sobre a abordagem do tema durante as consultas de pré-natal. Descritores: hipertensão gestacional; eclampsia; conhecimento; gestantes.RESUMENObjetivo: identificar los conocimientos sobre la hipertensión en el embarazo entre las mujeres embarazadas acompañadas en el servicio de salud primaria para el prenatal. Metodología: esto es un estudio seccional, del tipo survey, cuya población era de mujeres embarazadas atendidas en un Centro de Salud del Distrito Federal–DF, Brasil. Los criterios de selección fueron: ser mayor de 18 años, estar en el primer trimestre de embarazo y estar de acuerdo en participar en la investigación voluntariamente. Después del consentimiento, fue aplicado un cuestionario elaborado por las autoras. El estudio fue aprobado por el Comité de Ética en Investigación de la Fundação de Ensino e Pesquisa em Ciências da Saúde, con el Protocolo 191/09. Los datos fueron analizados por medio de la estadística descriptiva. Resultados: la muestra estuvo constituida por 30 mujeres, edad media de 26 años, la mayor parte de amas de casa. Acerca del conocimiento sobre la hipertensión en el embarazo, 77,33% había oído hablar del asunto, pero no fueron capazes de identificar aspectos de la prevención, factores de riesgo y las complicaciones de esa enfermedad. Conclusión: déficits en el conocimiento acerca de la hipertensión en el embarazo es un factor de riesgo de mortalidad para mujeres embarazadas. Se espera con los datos de este estudio alertar los profesionales de salud acerca de la abordaje del tema durante las consultas de prenatal. Descriptores: hipertensión en el embarazo; eclampsia; conocimiento; mujeres embarazadas.


2018 ◽  
Vol 6 (1) ◽  
pp. 39-44
Author(s):  
Carolina De Paula Orioli da Silva ◽  
Maria Cristina Almeida de Souza ◽  
José Carlos Dantas Teixeira ◽  
Elisa Maria Amorim da Costa ◽  
Paula Pitta de Resende Côrtes

Resumo: Introdução: A atenção obstétrica e neonatal prestada pelos serviços de saúde deve ter como características essenciais a qualidade e a humanização contribuindo assim para a melhoria dos cuidados oferecidos às gestantes e, consequentemente, para a melhoria dos indicadores de saúde materno-infantil. Objetivo: Caracterizar as gestantes da Unidade Estratégia de saúde da Família do bairro Itakamosi, em Vassouras/RJ.  Material e métodos: estudo documental, retrospectivo, com abordagem quantitativa, cujos dados foram coletados por meio da consulta aos prontuários das gestantes cadastradas e atendindas durante o ano de 2016. Resultados: A amostra foi constituída por 15 gestantes. Destas, 53,3% tinham entre 13 a 20 anos. Com relação ao estado civil, 53,3% eram solteiras. Sobre o número de gestações anteriores, 46,6% da amostra tinham 1 filho.Em relação ao número de abortos, 73,3% não tiveram. Sobre o número de consultas na assistência pré-natal realizada, realizaram menos de 6 consultas, 60% da amostra. Com relação ao trimestre que iniciaram o pré-natal, 60% da amostra o fizeram no 1º trimestre de gestação. Referente á imunização, 46,6% da amostra foi vacinada contra tétano, 73,3% contra hepatite B e 20% contra H1N1. Quanto ao tipo de parto, 80% realizaram cesariana. Com relação à consulta puerperal, 73,3% a realizaram. Conclusão: Conclui-se assim que pudemos obter uma caracterização plausível acerca das gestantes atendidas na Estratégia de Saúde da Família do bairro de Itakamosi, identificando possíveis fatores de riscos e quais intervenções podem ser feitas para promovere a promoção e prevenção em saúde.   Abstract Introduction: Obstetric and neonatal care provided by the health services must have quality and humanization characteristics, thus contributing to the improvement of the care offered to pregnant women and, consequently, to the improvement of maternal and child health indicators. Objective: To characterize the pregnant women of the Family Health Strategy Unit of Itakamosi neighborhood, in Vassouras / RJ. Material and methods: retrospective, documental study with a quantitative approach, whose data were collected through the medical records of pregnant women registered and attended during the year of 2016. Results: The sample consisted of 15 pregnant women. Of these, 53.3% were between 13 and 20 years old. Regarding marital status, 53.3% were single. About the number of previous pregnancies, 46.6% of the sample were in their first pregnancy. Regarding the number of abortions, 73.3% did not have any incidence. The number of medical consultations in prenatal care was less than 6 visits in 60% of the sample. For the trimester that the women began prenatal care, 60% of the sample started the medical supervision in the first trimester of pregnancy. Regarding immunization, 46.6% of the sample was vaccinated against tetanus, 73.3% against hepatitis B and 20% against H1N1. Regarding the type of delivery, 80% performed caesarean section. Regarding the puerperal consultation, 73.3% attended it. Conclusion: It was concluded that we could obtain a plausible characterization about the pregnant women assisted in the Family Health Strategy of the district of Itakamosi, identifying possible risk factors and which interventions can be made to promote health promotion and prevention. Key words: Pregnancy; Prenatal Care; Primary Health Care.


Sign in / Sign up

Export Citation Format

Share Document